Microbiome Therapeutics prepares to launch first microbiome modulator after completing Series B financing

261828b1-e8b6-4c71-a5dc-0270aa80590barticleimage.jpg

08 Nov 2017 --- MicroBiome Therapeutics, LLC (MBT), a company that applies the science of the gastrointestinal (GI) microbiome to promote health and wellness, has announced the completion of a Series B financing that raised approximately US$1 million. MBT intends to use the proceeds to launch its clinically-tested microbiome modulator product in 2018.

The dietary supplement is specifically designed to balance and optimize the GI tract and promote healthy metabolism by nourishing and nurturing the growth of healthful gut bacteria, MBT notes. New and existing investors include Lagniappe Angels, NO/LA Angel Network, Zehnder Communications and other private investors.

“We appreciate the support of our investors, which will enable the planned launch of our lead microbiome modulator next year,” says Dale Pfost, Acting CEO of MBT. “This product is a scientific formulation of natural ingredients designed to support a balanced GI microbiome and promote metabolic health in an easy-to-use, flavorful drink mix.”

“Our two clinical trials, conducted at the Pennington Biomedical Research Center and reported in peer-reviewed publications, demonstrated its benefits in helping to manage hunger, maintain healthy blood sugar levels and promote regularity,” Pfost adds.

The product is described as an all-natural blend of prebiotics, including fermentable fiber and polyphenol antioxidants in a patent-pending blend intended to help nurture and nourish beneficial microorganisms in the lower gut.

MBT reports that the launch of its microbiome modulator will be supported by a two-year e-commerce and social media campaign conducted in partnership with New Orleans-based advertising agency Zehnder Communications. MBT is also assembling a nationwide network of registered dietitians and certified diabetic educators to support the launch.

“With MicroBiome Therapeutics, we saw a unique opportunity to apply our product launch expertise in support of an exciting, first-in-class product from a leading science-based company,” says Jeremy Hunnewell, CFO and Business Strategist for Zehnder Communications. “We believe our expertise, along with our integrative and analytical approaches, will enable MBT to inform and educate consumers about this exciting new type of health-promoting dietary supplement.”

“Our investment reinforces our commitment to making a difference by playing a part in the microbiome revolution,” states Hunnewell, who will be joining the board of directors of MBT.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Labeling debate: Health labels may deter people from buying sugary drinks

25 May 2018 --- Young adults are less likely to buy sugar-sweetened beverages that include health labels, particularly those with graphic warnings about how added sugar can lead to tooth decay, obesity and Type 2 diabetes, according to research presented at this year's European Congress on Obesity (ECO) in Vienna this week. 

Nutrition & Health News

Weekly Digest: Arla expands fiber yogurt range, probiotics may reduce hay fever symptoms

25 May 2018 --- This week in nutrition news, Arla revealed a new addition to its fiber yogurt range, hoping to boost the UK's daily fiber intake. In research news, probiotic formulations were found to have positive effects on hay fever symptoms, while following a diet high in antioxidants may protect people from the adverse effects of pollution. Furthermore, researchers have made steps in understanding the link between a mothers nutrition during pregnancy and the child's growth, and a study undercovered that consumers are more likely to order unhealthy options when dining out amid louder, ambient music.

Nutrition & Health News

Avoid the snacks? To manage weight, timing of protein supplements matters

25 May 2018 --- Protein supplementation is finding its way into an ever-increasing range of formats, with on-the-go snacks and “bite-size” in particular seeing tremendous growth. However, new research by nutrition experts at Purdue University has shown that people looking to manage their weight with strength-training and protein supplements should consume their supplementation during a meal. 

Nutrition & Health News

DuPont's probiotic reach expands with Brazilian recognition of health claim

25 May 2018 --- DuPont Nutrition & Health Science has earned approval from the Brazilian Health Regulatory Agency (ANVISA) for its Bifidobacterium lactis HN019 probiotic strain. The regulatory green light marks the recognition of the science behind the strain and allows an on-pack health claim. Customers in Brazil can now bring new probiotic products and dietary supplements faster to market using the first DuPont probiotic to qualify for an approved health claim on the local market.

Nutrition & Health News

calocurb: 100 percent plant-based weight management product launched in US market

25 May 2018 --- New Zealand-based nutrition and e-commerce company calocurb has launched its 100 percent plant-based, non-GMO weight management supplement into the US market. The product is designed to curb cravings and reduce calorie intake by around 20 percent at meal or snack time.

More Articles
URL : http://www.nutritioninsight.com:80/news/microbiome-therapeutics-prepares-to-launch-first-microbiome-modulator-after-completing-series-b-financing.html